Athira Pharma, Inc. — Director's Dealing 2022

Mar 21, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2022-03-18

Reporting Person: Panzara Michael A. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
No securities are beneficially owned.	$0.00		Not Applicable (0)		Direct

Footnotes

F1: Not applicable.